Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07311278
NA

Identification of Sentinel Lymph Nodes Using Indocyanine Green in Breast Cancer Patients

Sponsor: St. Antonius Hospital

View on ClinicalTrials.gov

Summary

This study aims to evaluate the (inter)national implementation of a new diagnostic method for sentinel lymph node (SLN) detection in breast cancer. While Technetium-99m (99mTc) is the current gold standard for SLN detection, it has drawbacks such as limited availability, logistical challenges, radiation exposure, and potential side effects. Extensive research indicates that Indocyanine Green (ICG) is an equally effective and potentially more practical alternative. Conducting this study will help accelerate the implementation of ICG in clinical practice.

Official title: Identification of Sentinel Lymph Nodes in Breast Cancer Patients Through Non-invasively Fluorescent Imaging Using Indocyanine Green: an International Multicenter Implementation Study.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

493

Start Date

2023-06-08

Completion Date

2026-10

Last Updated

2025-12-30

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Phase I: Technetium is administered as single tracer to identify the SLN (current standard).

During this phase, surgeons will use technetium to identify the SLN as this is the current standard of care. This phase will serve as a control group.

PROCEDURE

Phase II: SLN biopsy using double tracer technetium and ICG (learning curve)

During this phase, surgeons will primarily use ICG to identify the sentinel lymph node (SLN), while technetium will serve as a control. This approach allows surgeons to gain proficiency with ICG-guided SLN biopsy and safely advance through the learning curve.

PROCEDURE

Phase III: ICG is administered as single tracer to identify the SLN (alternative method).

During this phase, surgeons will use ICG as a singe tracer to identify the SLN.

Locations (11)

Ospedale Pederzoli

Peschiera del Garda, Italy

Jeroen Bosch Ziekenhuis

's-Hertogenbosch, Netherlands

FlevoZiekenhuis

Almere Stad, Netherlands

Antoni van Leeuwenhoek Ziekenhuis

Amsterdam, Netherlands

Reinier de Graaf Gasthuis

Delft, Netherlands

Van Weel-Bethesda Ziekenhuis

Dirksland, Netherlands

Maastricht Universitair Medisch Centrum

Maastricht, Netherlands

Erasmus Medisch Centrum

Rotterdam, Netherlands

HagaZiekenhuis

The Hague, Netherlands

Bernhoven Ziekenhuis

Uden, Netherlands

Isala Ziekenhuis

Zwolle, Netherlands